Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.86B |
| 2 |
Apple
AAPL
|
+$2.18B |
| 3 |
Microsoft
MSFT
|
+$1.47B |
| 4 |
Amazon
AMZN
|
+$943M |
| 5 |
Alibaba
BABA
|
+$864M |
Top Sells
| 1 |
Keurig Dr Pepper
KDP
|
+$187M |
| 2 |
BFT.U
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
|
+$178M |
| 3 |
NIO
NIO
|
+$156M |
| 4 |
Oracle
ORCL
|
+$151M |
| 5 |
PayPal
PYPL
|
+$148M |
Sector Composition
| 1 | Technology | 18.9% |
| 2 | Consumer Discretionary | 12.17% |
| 3 | Healthcare | 12.05% |
| 4 | Financials | 9.25% |
| 5 | Industrials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Exelon
EXC
$43.9B
| $20.3M | 0.01% |
675,418
-157,934
| -19% | -$4.76M |
|
752
Tandem Diabetes Care
TNDM
$864M
| $20.2M | 0.01% |
211,538
-120,933
| -36% | -$11.6M |
|
|
BFX
753
DELISTED
BowFlex Inc.
BFX
| $20.2M | 0.01% |
+1,115,702
| New | +$20.2M |
|
754
Aecom
ACM
$16.9B
| $20.2M | 0.01% |
406,008
-289,670
| -42% | -$14.4M |
|
755
GeneDx Holdings
WGS
$3.62B
| $20.1M | 0.01% |
+55,302
| New | +$20.1M |
|
756
Novavax
NVAX
$1.34B
| $20.1M | 0.01% |
180,521
-128,760
| -42% | -$14.4M |
|
|
ACIC
757
DELISTED
Atlas Crest Investment Corp.
ACIC
| $20.1M | 0.01% |
+1,999,998
| New | +$20.1M |
|
758
New Jersey Resources
NJR
$4.76B
| $20.1M | 0.01% |
564,894
+219,894
| +64% | +$7.82M |
|
759
Take-Two Interactive
TTWO
$45.5B
| $20.1M | 0.01% |
96,625
-45,928
| -32% | -$9.54M |
|
|
BWIN
760
Baldwin Insurance Group
BWIN
$2.21B
| $20M | 0.01% |
668,957
+624,199
| +1,395% | +$18.7M |
|
761
WillScot Mobile Mini Holdings
WSC
$4.29B
| $20M | 0.01% |
864,767
-620,558
| -42% | -$14.4M |
|
|
VYGG
762
DELISTED
Vy Global Growth
VYGG
| $20M | 0.01% |
+1,920,000
| New | +$20M |
|
763
M&T Bank
MTB
$30.9B
| $20M | 0.01% |
156,723
-104,607
| -40% | -$13.3M |
|
764
Dr. Reddy's Laboratories
RDY
$12.3B
| $19.9M | 0.01% |
1,397,525
+1,357,860
| +3,423% | +$19.4M |
|
765
Bausch Health
BHC
$2.68B
| $19.9M | 0.01% |
955,989
+425,057
| +80% | +$8.84M |
|
766
Tronox
TROX
$793M
| $19.9M | 0.01% |
1,359,397
+840,486
| +162% | +$12.3M |
|
767
NovoCure
NVCR
$1.42B
| $19.8M | 0.01% |
114,708
+75,265
| +191% | +$13M |
|
768
Travere Therapeutics
TVTX
$2.23B
| $19.8M | 0.01% |
727,176
-138,933
| -16% | -$3.79M |
|
769
Gen Digital
GEN
$18.3B
| $19.8M | 0.01% |
953,488
+861,789
| +940% | +$17.9M |
|
770
Diageo
DEO
$57.6B
| $19.8M | 0.01% |
124,746
+81,394
| +188% | +$12.9M |
|
771
Maravai LifeSciences
MRVI
$404M
| $19.8M | 0.01% |
+705,698
| New | +$19.8M |
|
772
Avis
CAR
$5.53B
| $19.7M | 0.01% |
527,507
+126,107
| +31% | +$4.7M |
|
773
RingCentral
RNG
$2.83B
| $19.6M | 0.01% |
51,805
-59,832
| -54% | -$22.7M |
|
774
Acadia Pharmaceuticals
ACAD
$4.08B
| $19.6M | 0.01% |
367,111
-224,421
| -38% | -$12M |
|
775
Flowserve
FLS
$7.41B
| $19.6M | 0.01% |
531,866
+287,224
| +117% | +$10.6M |
|